Sign up for free insights newsletter
IZ

Izotropic Corporation

IZOZFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$0.21
+1.40%
End of day
Market Cap

$11.01M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino25.920.66-0.990.333.68
Calmar1.46-0.970.380.20
Sharpe11.480.41-0.670.221.61
Omega197.632.051.180.891.1414.30
Martin3.33-1.390.750.68
Ulcer0.064.7513.0042.7831.3625.10

Izotropic Corporation (IZOZF) Price Performance

Izotropic Corporation (IZOZF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.21, up 1.40% from the previous close.

Over the past year, IZOZF has traded between a low of $0.14 and a high of $0.35. The stock has gained 8.8% over this period. It is currently 40.3% below its 52-week high.

Izotropic Corporation has a market capitalization of $11.01M.

About Izotropic Corporation

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

Compare Izotropic Corporation

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
N/A
EBITDA
$-2,457,489
Profit Margin
N/A
EPS (TTM)
-0.03
Book Value
-0.06

Technical Indicators

52 Week High
$0.37
52 Week Low
$0.12
50 Day MA
$0.18
200 Day MA
$0.22
Beta
2.20

Valuation

Trailing P/E
N/A
Forward P/E
2.00
Price/Sales
N/A
Price/Book
115.81
Enterprise Value
$12.95M